News | January 20, 2012

BridgePoint Licensing CTO Peripheral Vascular Products to Covidien

January 20, 2012 - BridgePoint Medical Inc. this week signed an agreement with Covidien to exclusively license the rights to its peripheral vascular products used to treat chronic total occlusions (CTO).  The agreement includes the BigBoss and Mantaray catheters and the Mantaray guidewire. The terms of the agreement were not disclosed.

“This is a fantastic achievement for BridgePoint Medical,” said Denis Harrington, CEO and president, BridgePoint Medical. “We are pleased with this transaction and expect that this agreement will be a positive development for all BridgePoint shareholders.”

The bulk of BridgePoint Medical's assets including the coronary chronic total occlusion (CTO) products, intellectual property, its employees and all other non-vascular applications will remain with the company.

BridgePoint Medical, Inc. is a privately held company established in 2006 to design, develop and commercialize new technologies and techniques to treat challenging coronary artery disease.

The Mantaray catheter was cleared by the U.S, Food and Drug Administration in August 2011. The BigBoss cathter was cleared in January 2012.

For more information:


Related Content

Reflow Medical's Wingman Crossing Catheter Receives FDA Clearance for Coronary Indication
News | Catheters | October 02, 2017
October 2, 2017 — Reflow Medical Inc. announced that the company has received 510(k) clearance from the U.S.
Roxwood Medical Announces Agreement With Abbott for U.S. Product Distribution
News | Catheters | August 09, 2017
Roxwood Medical Inc. recently announced it has entered into an exclusive agreement with Abbott for distribution of...
Teleflex, FDA 510k clearance, TrapLiner Catheter, U.S. launch
Technology | Catheters | March 02, 2017
Teleflex Inc. has announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and U.S. commercial launch...
Merit Medical Systems, SwiftNINJA Steerable Microcatheter, FDA 510(k) clearance
Technology | Catheters | November 09, 2016
November 9, 2016 — Merit Medical Systems Inc.
VentureMed Group, Flex Scoring Catheter, FDA approval, peripheral arterial disease, PAD, endovascular treatment
Technology | Catheters | July 13, 2016
July 13, 2016 — VentureMed Group Ltd., specializing in devices for the endovascular treatment of...
Roxwood Medical, MicroCross Catheter, full U.S. launch

Image courtesy of Roxwood Medical

Technology | Catheters | January 07, 2016
Roxwood Medical Inc. reported that more than 500 patients have been successfully treated as part of the initial limited...
Overlay Init